Allergan restructuring will result in cuts of 450 employees, including COO Haugen.
This article was originally published in The Tan Sheet
Executive Summary
ALLERGAN RESTRUCTURING TO RESULT IN CUTS OF 450 EMPLOYEES, including 15 of the top 80 positions in the corporation, Allergan told analysts at a June 3 meeting. Among the positions being eliminated is chief operating officer; COO Richard Haugen is resigning effective June 30. The company also is consolidating manufacturing capabilities with the closure of several facilities.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning